# FDA Inspection 922850 - Biogen U.S. Corporation - April 16, 2015

Source: https://www.keypedia.com/records/fda_inspections/biogen-us-corporation/40bbf281-d8a8-419b-84bc-3233f4f5fd05
Source feed: FDA_Inspections

> FDA Inspection 922850 for Biogen U.S. Corporation on April 16, 2015. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 922850
- Company Name: Biogen U.S. Corporation
- Inspection Date: 2015-04-16
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1220500 - 2023-10-17](https://www.keypedia.com/records/fda_inspections/biogen-us-corporation/900286c7-188d-48a4-afa8-5f32b90599d4)
- [FDA Inspection 1178753 - 2022-08-26](https://www.keypedia.com/records/fda_inspections/biogen-us-corporation/18ae21fa-5a13-4593-9c58-0da5ea5a296b)
- [FDA Inspection 951256 - 2015-12-10](https://www.keypedia.com/records/fda_inspections/biogen-us-corporation/a4fdbe55-da8d-4738-9432-7b6e0b4b439c)

Company: https://www.keypedia.com/companies/biogen-us-corporation/515ce53c-77be-414c-bcf4-c66be60b098e

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c